Acasti Pharma Reports on Positive Feedback Following Today’s Presentation at the XVIII International Symposium on Atherosclerosis Jun 11, 2018
Acasti Pharma Retains Crescendo Communications for Investor Relations Services in the United States May 18, 2018
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures Apr 2, 2018
Acasti Pharma Announces First Patient Randomized in Pivotal TRILOGY Phase 3 Program of CaPre in Severe Hypertriglyceridemia Mar 14, 2018
Acasti Pharma Announces the Closing of Over-Allotment Option for its Public Offering of Common Shares Jan 22, 2018
